Literature DB >> 21576271

Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening.

Lydia Guittet1, Elodie Guillaume, Romuald Levillain, Philippe Beley, Jean Tichet, Olivier Lantieri, Guy Launoy.   

Abstract

BACKGROUND: The superiority of several immunochemical fecal occult blood tests (I-FOBT) over guaiac-based tests in colorectal cancer screening is now established. The aim of this study was to compare the analytical performance of 3 quantitative I-FOBTs.
METHODS: Stool samples from 10 healthy volunteers, initially I-FOBT negative, supplemented with human blood, were used to compare reproducibility and stability of measurement at varying storage temperatures (4°C, 10°C, 20°C, and 30°C) and durations before test analysis (1 to 10 days) for 3 I-FOBTs (New Hemtube/Magstream HT, OC-Auto sampling bottle3/OC-Sensor DIANA, and FOB Gold/SENTiFOB). Concentrations ranging from 0 to 350 μg Hb/g of feces were evaluated.
RESULTS: The measurement reproducibility of OC-Sensor was superior to Magstream and far superior to FOB Gold. For all tests, variability was essentially related to sampling. Detected hemoglobin (Hb) levels were substantially lower for all tests at temperatures above 20°C. At 20°C, this loss in concentration was less important with OC-Sensor (significant 1.7% daily decrease vs. 7.4% for Magstream and 7.8% for FOB Gold). At 30°C, daily loss was 8.6% with OC-Sensor, whereas after 24 hours, only 30% of the original Hb was detected with FOB Gold, compared to 70% with Magstream. No Hb was detected on day 5 for the latter 2 tests.
CONCLUSIONS: About reproducibility and temperature stability, OC-Sensor performed better than Magstream and far better that FOB Gold. IMPACT: Independently of the chosen test, the delay between sampling and test processing should be reduced, the maximal admissible delay depending on ambient temperature. ©2011 AACR

Entities:  

Mesh:

Year:  2011        PMID: 21576271     DOI: 10.1158/1055-9965.EPI-10-0594

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  6 in total

Review 1.  Faecal occult blood testing for colorectal cancer screening: the past or the future.

Authors:  Sally C Benton; Helen E Seaman; Stephen P Halloran
Journal:  Curr Gastroenterol Rep       Date:  2015-02

2.  Evaluation of fecal immunochemical tests for colorectal cancer screening.

Authors:  Jeanette M Daly; Camden P Bay; Barcey T Levy
Journal:  J Prim Care Community Health       Date:  2013-05-12

Review 3.  Colorectal cancer screening--optimizing current strategies and new directions.

Authors:  Ernst J Kuipers; Thomas Rösch; Michael Bretthauer
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

4.  Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).

Authors:  Gemma Binefa; Montse Garcia; Núria Milà; Esteve Fernández; Francisco Rodríguez-Moranta; Núria Gonzalo; Llúcia Benito; Ana Clopés; Jordi Guardiola; Víctor Moreno
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

5.  Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening.

Authors:  Anton Gies; Katarina Cuk; Petra Schrotz-King; Hermann Brenner
Journal:  Clin Transl Gastroenterol       Date:  2018-07-06       Impact factor: 4.488

Review 6.  Advances in Fecal Occult Blood Tests: the FIT revolution.

Authors:  Graeme P Young; Erin L Symonds; James E Allison; Stephen R Cole; Callum G Fraser; Stephen P Halloran; Ernst J Kuipers; Helen E Seaman
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.